Related references
Note: Only part of the references are listed.Structural and mechanistic insights into fungal β-1,3-glucan synthase FKS1
Xinlin Hu et al.
NATURE (2023)
Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor
James M. Apgar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor
Sabelle Jallow et al.
JOURNAL OF FUNGI (2021)
Ibrexafungerp to treat acute vulvovaginal candidiasis
Maria Chiara Masone
NATURE REVIEWS UROLOGY (2021)
SCY-078, a Novel Fungicidal Agent, Demonstrates Distribution to Tissues Associated with Fungal Infections during Mass Balance Studies with Intravenous and Oral [14C] SCY-078 in Albino and Pigmented Rats
Stephen Wring et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Enfumafungin synthase represents a novel lineage of fungal triterpene cyclases
Eric Kuhnert et al.
ENVIRONMENTAL MICROBIOLOGY (2018)
De Novo Acquisition of Resistance to SCY-078 in Candida glabrata Involves FKS Mutations That both Overlap and Are Distinct from Those Conferring Echinocandin Resistance
Cristina Jimenez-Ortigosa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin
James M. Apgar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)
Michael A. Pfaller et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthase
Brian H. Heasley et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
New β-glucan inhibitors as antifungal drugs
Richard F. Hector et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Lobarialides A-C, Antifungal Triterpenoids from the Lichen Lobaria kurokawae
Xiao-Ning Wang et al.
CHEMISTRY & BIODIVERSITY (2009)
Fernene Triterpenoids from the Lichen Pyxine berteriana
Marta S. Maier et al.
JOURNAL OF NATURAL PRODUCTS (2009)
Kolokosides A-D:: Triterpenoid glycosides from a Hawaiian isolate of Xylaria sp.
Stephen T. Deyrup et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole
H Quan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Enzymatic deglycosylation of enfumafungin, a triterpene glycoside natural product, and its chemically synthesized analogues
A Shafiee et al.
JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC (2001)
Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides
GA Kaminski et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2001)
The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species biological activity and taxonomy of the producing organisms
F Peláez et al.
SYSTEMATIC AND APPLIED MICROBIOLOGY (2000)
Isolation and structural determination of enfumafungin, a triterpene glycoside antifungal agent that is a specific inhibitor of glucan synthesis
RE Schwartz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Discovery of novel antifungal (1,3)-β-D-glucan synthase inhibitors
J Onishi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
